Literature DB >> 16325467

Distribution of paresthesias in Carpal Tunnel Syndrome reflects the degree of nerve damage at wrist.

Pietro Caliandro1, Giuseppe La Torre, Irene Aprile, Costanza Pazzaglia, Irene Commodari, Pietro Tonali, Luca Padua.   

Abstract

OBJECTIVE: To verify whether the distribution of paresthesias in patients with Carpal Tunnel Syndrome (CTS) is related to the degree of the neurophysiological involvement.
METHODS: We performed a cross-sectional study and retrospectively evaluated 163 patients who referred to our electromyography lab and to which a clinical and electrophysiological diagnosis of CTS was made. We divided the patients into two groups: (1) patients complaining of paresthesias at the hand as a whole and (2) patients with paresthesias in the territory of the median nerve. We referred to the distribution of paresthesias at the hand as GLOVE and to the distribution in the territory of the median nerve as MEDIAN. We compared the neurophysiological impairment in GLOVE and MEDIAN distributions. Moreover, we performed multiple regression analysis to evaluate which clinical-neurophysiological variables determined GLOVE and MEDIAN distribution.
RESULTS: In our sample, 70.4% of patients had GLOVE distribution and 29.6% of patients MEDIAN distribution. The risk of presenting MEDIAN distribution increases about twice (OR = 2.07; 95% IC: 1.51-2.83) for each unitary increment of neurophysiological class.
CONCLUSIONS: The distribution of paresthesias reflects the degree of nerve damage at wrist; patients suffering of SEV/EXT CTS present MEDIAN distribution. SIGNIFICANCE: Our data have important clinical implications because they strongly suggest that we have to consider the possibility of a severe neurophysiological involvement of the median nerve at wrist in patients complaining of MEDIAN distribution.

Entities:  

Mesh:

Year:  2005        PMID: 16325467     DOI: 10.1016/j.clinph.2005.09.001

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

1.  Is the Control of Applied Digital Forces During Natural Five-digit Grasping Affected by Carpal Tunnel Syndrome?

Authors:  Po-Tsun Chen; I-Ming Jou; Chien-Ju Lin; Hsiao-Feng Chieh; Li-Chieh Kuo; Fong-Chin Su
Journal:  Clin Orthop Relat Res       Date:  2015-02-18       Impact factor: 4.176

2.  Quality measures for the diagnosis and non-operative management of carpal tunnel syndrome in occupational settings.

Authors:  Teryl Nuckols; Philip Harber; Karl Sandin; Douglas Benner; Haoling Weng; Rebecca Shaw; Anne Griffin; Steven Asch
Journal:  J Occup Rehabil       Date:  2011-03

Review 3.  Nerve conduction studies and EMG in carpal tunnel syndrome: Do they add value?

Authors:  Masahiro Sonoo; Daniel L Menkes; Jeremy D P Bland; David Burke
Journal:  Clin Neurophysiol Pract       Date:  2018-04-05

Review 4.  The effectiveness of manual therapy on pain, physical function, and nerve conduction studies in carpal tunnel syndrome patients: a systematic review and meta-analysis.

Authors:  Sandra Jiménez-Del-Barrio; Aida Cadellans-Arróniz; Luis Ceballos-Laita; Elena Estébanez-de-Miguel; Carles López-de-Celis; Elena Bueno-Gracia; Albert Pérez-Bellmunt
Journal:  Int Orthop       Date:  2021-12-03       Impact factor: 3.479

5.  Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled Trial.

Authors:  Sandra Jiménez-Del-Barrio; Luis Ceballos-Laita; Elena Bueno-Gracia; Sonia Rodríguez-Marco; Santos Caudevilla-Polo; Elena Estébanez-de-Miguel
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

6.  The construct validity and responsiveness of sensory tests in patients with carpal tunnel syndrome.

Authors:  Derek K M Cheung; JoyC MacDermid; Dave Walton; Ruby Grewal
Journal:  Open Orthop J       Date:  2014-05-16

7.  Axonal degeneration of the ulnar nerve secondary to carpal tunnel syndrome: fact or fiction?

Authors:  Radwa Mahmoud Azmy; Amira Ahmed Labib; Saly Hassan Elkholy
Journal:  Neural Regen Res       Date:  2013-05-25       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.